Office of the President - Clinical Affairs - Administration.

Medicine & Life Sciences

1. Hepatitis 100%
2. Liver 87%
3. Alcoholic Hepatitis 73%
4. Liver Diseases 59%
5. Biliary Liver Cirrhosis 57%
6. Alcohols 46%
7. Liver Transplantation 38%
8. Hepatitis B 37%
9. Hepatic Encephalopathy 32%
10. Therapeutics 27%
11. Fibrosis 23%
12. Pharmaceutical Preparations 22%
13. Budd-Chiari Syndrome 21%
14. Chemical and Drug Induced Liver Injury 21%
15. Wounds and Injuries 21%
16. Serum 21%
17. Hepatitis C 19%
18. Adrenal Cortex Hormones 19%
19. Alcoholic Liver Diseases 19%
20. Chronic Hepatitis B 19%
21. Sclerosing Cholangitis 18%
22. Ribavirin 17%
23. Placebos 15%
24. Ursodeoxycholic Acid 15%
25. Bilirubin 15%
26. Chronic Brain Damage 14%
27. Synthetic Vaccines 14%
28. Hepatitis B virus 14%
29. Lactulose 14%
30. Isoniazid 14%
31. Chronic Hepatitis 14%
32. Neomycin 13%
33. Hepatitis B Antigens 13%
34. Bile 13%
35. Hepacivirus 12%
36. Safety 12%
37. Survival 12%
38. Methyldopa 11%
39. Ethanol 11%
40. Massive Hepatic Necrosis 11%
41. Biopsy 11%
42. Keratin-18 11%
43. Vaccination 11%
44. Prolyl Hydroxylases 11%
45. Mortality 10%
46. Interferons 10%
47. Pentoxifylline 10%
48. Vaccines 10%
49. Infections 10%
50. Phlebography 9%
51. Hepatitis B Surface Antigens 9%
52. Alcoholics 9%
53. Asian Americans 9%
54. Registries 9%
55. Antigens 9%
56. Necrosis 9%
57. Fatty Liver 9%
58. K-18 conjugate 9%
59. Hepatocellular Carcinoma 9%
60. Managed Care Programs 9%
61. Gastroenterologists 8%
62. Zinc 8%
63. Gallstones 8%
64. Prednisolone 8%
65. Keto Acids 8%
66. Dietary Proteins 8%
67. End Stage Liver Disease 8%
68. Ascites 8%
69. Acetaminophen 8%
70. Hepatocytes 8%
71. Vasopressins 8%
72. Sorbitol 7%
73. Chemical and Drug Induced Liver Injury, Chronic 7%
74. Immunoglobulins 7%
75. Collagen 7%
76. Transaminases 7%
77. Chronic Hepatitis C 7%
78. Skin 7%
79. Pulmonary Wedge Pressure 7%
80. Bile Acids and Salts 7%
81. Mesenteric Veins 7%
82. Engerix-B 7%
83. Pregnancy 7%
84. progabide 7%
85. Erythromycin Ethylsuccinate 7%
86. Superior Mesenteric Artery 7%
87. macitentan 7%
88. Public Health 7%
89. Lipoprotein-X 7%
90. Nervous System Mercury Poisoning 6%
91. Aprindine 6%
92. Paraldehyde 6%
93. Education 6%
94. Stents 6%
95. Biomarkers 6%
96. Chronic Disease 6%
97. Hepatitis Antibodies 6%
98. baysilon 6%
99. Essential Amino Acids 6%
100. Myeloproliferative Disorders 6%